Clinical Assessment Of Age-related Macular Degeneration Patients After Early Diagnosis and Treatment With Ranibizumab

Stopped early · Phase 2/Phase 3

Conditions studied: Age-Related Macular Degeneration

In brief

To determine if patients treated early after diagnosis of wet age-related macular degeneration can return/maintain to their baseline pre-disease BCVA.

Key facts

Study ID
NCT01402544
Run by
University of California, San Diego
People needed
20
Starts
2011-07-01
Expected to finish
2015-03-01
Last updated by the study team
2019-08-28

Who can join

Age: 50 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.